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Soft tissue sarcomas
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Purpose. To analyze if a dose-response relationship exists for soft tissue sarcoma (STS) of the extremities treated with maximum
surgical resection and intraoperative electron therapy (IOeRT) with or without external beam radiotherapy (EBRT).
Materials and methods. A multicentric pooled analysis was conducted to analyze the outcome of STS treated with surgery and
intraoperative electron therapy. We have selected 138 patients with STS of the extremities. Tumor was primary in 123 patients
vs 15 recurrences. Median age at diagnosis was 52y. Median largest tumor diameter was 10 cm. Histologic type was liposarcoma
in 41 cases, malignant ﬁbrous histiocytoma in 23, leyomiosarcoma in 18, and others in 56 cases. Histologic gade was G1 in 18, G2
in 47 and G3 in 64. Treatment consisted in maximum surgical resection (R0 in 112 cases, R1 in 25 cases) plus IOeRT (median dose
= 12.5Gy, range 7.5–20Gy) and EBRT in 123 patients (median dose = 50Gy, range 25.2–60.4Gy) Patient factors, tumor factors and
treatment factors were analyzed using univariate and multivariate analysis to evaluate correlations with the study endpoints. A
linear-quadratic analysis was performed to avoid fractionation effect, and to normalize the dose. Values for total physical dose
(IOeRT + EBRT) were transformed into BED (biological effective dose). A dose-response analysis was performed. Dose bins were
calculated andunivariate survival analysis (Kaplan–Meiermethod)was performed for each dose bin. This analysiswas performed
for the whole group and for R0 and R1 subgroups. Survival rates were then ﬁt to a logistic model: p=d1+ ([d2−d1]/[(1 + exp
[sigma50× (D−TCD50)]]). The relative steepness of the curve (gamma50) was calculated: gamma50=TCD50× sigma50
Results. Resection status (R0 vs. R1) was the only signiﬁcant factor for local control in multivariate analysis. Five year and ten year
local relapse free survival were 85% and 85% for R0 subgroup and 65% and 46% for R1 subgroup (p=0.0013). For R0, two dose bins
(cutoff for BED=40) were identiﬁed giving 3yLRFS 88% vs 74% (p=0.045). For R1, two dose bins (cutoff for BED=75) were identiﬁed
giving 3yLRFS 70% vs 33% (p=0.02). A dose-response curve was created. Table 1 shows the parameters for the two subgroups.
Conclusion. The use of LQ model remains controversial for large doses per fraction. However, we have found a way to analyze
la long series of STS of the extremities and we have found a good ﬁt of the BED to a logistic function giving clinically relevant
results suggesting a dose effect for R1 tumors.
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Introduction. Since the constitution in 2006 of the Soft Tissue Tumor Unit (STTU) we have received in our center 25 cases of this
rare ﬁbromatosis. It represents 5% of the total STT from our center. We reviewed these cases and evaluated the therapeutic
decision making.
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